Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 June 2025 | Story Onthatile Tikoe | Photo Supplied
Logan James
Logan W. James, UFS alumnus and breakout star of Binnelanders Season 15, proudly waves the Kovsie flag as he steps into his first national television role.

University of the Free State (UFS) alumnus Logan W James made his national television debut in Season 15 of kykNET’s long-running medical drama, Binnelanders. Streaming on Showmax from 4 June 2025, the latest season introduces Logan in a role that delivers high drama, high energy, and a fresh wave of talent rooted in the Free State.

 

From campus to camera

Born and bred in Bloemfontein, Logan’s rise from student theatre to the small screen is a story stitched together by grit, passion, and a deep love for performance. A former learner of Grey College and a proud Kovsie, Logan honed his craft at the University of the Free State, where he quickly became known for his magnetic stage presence and commitment to his roles.

From standout performances in Everyman, How to Wuzz, and Run for Your Wife to unforgettable moments during UFS’s annual Africa Day showcases, Logan carved out a name for himself as a rising star on campus – one performance at a time.

 

A dream years in the making

Now based in Johannesburg, Logan is stepping into a new kind of spotlight. He plays Le Roux Snyman - a thrill-seeking, motocross-riding character with a bold facade and hidden depths.

“Le Roux is full of energy and contradictions,” Logan says. “He lives for extreme sports and adrenaline, but there’s a much softer, more vulnerable side he doesn’t often show. What excites me is exploring both boldness and fragility in the same breath - it’s something I’ve never quite done before.”

Though this may be Logan’s TV debut, stepping onto the Binnelanders set felt strangely familiar.

“I used to watch Binnelanders at my grandmother’s house,” he recalls. “Never in my wildest dreams did I imagine I’d one day be part of the cast. It feels like a full-circle moment - a dream realised. The journey here wasn’t straightforward, but seeing it come to life like this is an incredible blessing.”

 

The foundation of theatre

Logan credits his Bloemfontein theatre roots as the foundation of his acting journey. “Theatre taught me discipline, presence, and heart,” he says. “On stage, there are no second takes. You have to show up, fully and honestly, every time. That kind of intensity trains you not as a performer, but as a professional.

These lessons continue to shape how he approaches his work today. “Kindness and professionalism – those are the two things I carry into every production,” he adds.

 

Big city, bigger lessons

The move from Bloem’s close-knit creative community to the bustling entertainment industry in Johannesburg came with new challenges – and new lessons.

“In Joburg, you quickly realise just how much talent is out there,” Logan says. “It forced me to embrace what makes me unique, rather than compare myself to others. Real passion – not the pursuit of fame – is what carries you through the tough times. If you’re chasing the art, not the spotlight, you’ll find purpose, even when things get hard.”

 

A voice for regional talent

Logan’s journey is not just a personal triumph – it’s also a win for regional talent. As a Free State-born actor breaking into the national scene, he is part of a growing wave of creatives proving that national recognition is possible from anywhere.

“To go from student theatre to national TV is a leap that’s both terrifying and thrilling,” Logan reflects. “But it's proof that consistent hard work, staying true to your craft, and trusting the process can open doors you once only dreamed of.”

 

Ready for the spotlight

With his first episode having aired on 4 June, audiences were treated to a performance that was rich with energy and layered with emotion.

“There’s a lot of growth ahead - for Le Roux and for me,” Logan shares. “I’m looking forward to every moment of it. I can’t wait for South Africa to meet him.”

News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies  Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.

Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept